Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 1/20 | 0.59 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.59 |
| ▸ | CDK2 | P24941 | 1/20 | 0.59 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.59 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 2/20 | 0.42 |
| ▸ | CHAT | P28329 | 1/20 | 0.42 |
| ▸ | ATIC | P31939 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL28920660 | 0.88 | TTR (0.50) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL1809155 | 0.87 | TTR (0.53) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL465006 | 0.87 | CDK2 (0.53) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL29360969 | 0.85 | TTR (0.58) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL10598159 | 0.85 | TTR (0.51) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL153141 | 0.85 | MAPT (0.57) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL7744816 | 0.85 | TTR (0.51) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL343611 | 0.85 | TTR (0.51) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL179823 | 0.85 | TTR (0.58) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL10598162 | 0.85 | TTR (0.51) | TTRFABP4CCNA2CDK2MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102417839-A | Fuel antistatic agent and application thereof | OIL RES INST OF THE AIR FORCE PLA | 2012-04-18 | — | — | CN | claimed |
| EP-1438006-A1 | METHOD OF COLOURING KERATIN-CONTAINING FIBRES USING DIAZONIUM SALTS | Ciba SC Holding AG (CH) | 2004-07-21 | — | — | EP | claimed |
| WO-2003032939-A1 | METHOD OF COLOURING KERATIN-CONTAINING FIBRES USING DIAZONIUM SALTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-04-24 | — | — | WO | claimed |
| EP-0218097-B1 | STABILIZED AQUEOUS HYDROGEN PEROXIDE SOLUTION | Bayer Corporation (US) | 1992-01-15 | — | — | EP | claimed |
| EP-0244167-B1 | IMPROVED PROCESS FOR PREPARING POLY (ARYL ETHERS) AND POLY (ARYL ETHER KETONES) | AMOCO CORPORATION (US) | 1990-04-04 | — | — | EP | claimed |
| EP-0218097-A2 | Stabilized aqueous hydrogen peroxide solution | Bayer Corporation (US) | 1987-04-15 | — | — | EP | claimed |
| US-20250296933-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-09-25 | — | — | US | disclosed |
| US-12242190-B2 | Photoacid generator for chemically amplified photoresists | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2025-03-04 | — | — | US | disclosed |
| US-20230346794-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| WO-2023180171-A1 | METHYLENE BLUE CONTAINING COMPOUNDS FOR THE TREATMENT OF METHAEMOGLOBINAEMIA | WISTA LABORATORIES LTD (SG) | 2023-09-28 | — | — | WO | disclosed |
| US-11759469-B2 | Administration and dosage of diaminophenothiazines | WISTA LABORATORIES LTD. (SG) | 2023-09-19 | — | — | US | disclosed |
| EP-4223297-A2 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WisTa Laboratories Ltd. (SG) | 2023-08-09 | — | — | EP | disclosed |
| US-20230165875-A1 | METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19 | WISTA LABORATORIES LTD. (SG) | 2023-06-01 | — | — | US | disclosed |
| US-4786581-A | Gumming solution for use in the burning-in of offset-printing plates comprising water, a hydrophilic polymer and an organic acid derivative | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-11-22 | — | — | US | disclosed |
| US-4744968-A | AROMATIC SULFONIC ACIDS, ACETANILIDE | TECHNICON INSTRUMENTS CORPORATION (US) | 1988-05-17 | — | — | US | disclosed |
| EP-0218097-A2 | Stabilized aqueous hydrogen peroxide solution | Bayer Corporation (US) | 1987-04-15 | — | — | EP | disclosed |
| US-4590273-A | NEUROLEPTIC HYPOTENSIVE AND ANTIARRHYTHMIC AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-05-20 | — | — | US | disclosed |
| EP-0155620-A2 | Burning-in and gumming for lithographic plates, and process for the preparation of a lithograhic plate | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-09-25 | — | — | EP | disclosed |
| EP-0047923-B1 | ISOQUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-05-09 | — | — | EP | disclosed |
| EP-0047923-A1 | Isoquinoline derivatives, processes for their preparation and pharmaceutical compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296933-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | CYP11B1, CYP11A1, CYP11B2 | TTR 440/4885FABP4 2554/4885CCNA2 3004/4885 |
| US-11759469-B2 | Administration and dosage of diaminophenothiazines | ACHE, BCHE, PNMT | TTR 229/4885FABP4 4785/4885CCNA2 2745/4885 |
| US-20230346794-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | ACHE, BCHE, PNMT | TTR 186/4885FABP4 4800/4885CCNA2 2601/4885 |
| US-20230165875-A1 | METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19 | ACE2, BHMT2, ACE | TTR 1128/4885FABP4 3235/4885CCNA2 4264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.